Log In
Print
BCIQ
Print
Print this Print this
 

TO-2070

  Manage Alerts
Collapse Summary General Information
Company Shin Nippon Biomedical Laboratories Ltd.
DescriptionIntranasal formulation of dihydroergotamine (DHE)
Molecular Target Serotonin (5-HT) receptor
Mechanism of ActionSerotonin (5-HT) receptor agonist
Therapeutic ModalitySmall molecule
Latest Stage of DevelopmentPreclinical
Standard IndicationMigraine
Indication DetailsTreat acute migraine
Regulatory Designation

Partner


 Product Details
 Archive Items are loading loading
Get a free BioCentury trial today